動脈切開封堵器市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

全球動脈切開術閉合裝置市場規模預計在 2024 年達到 19.4 億美元，從 2025 年的 20.8 億美元成長到 2033 年的 37.1 億美元，在預測期（2026-2033 年）內複合年成長率為 7.5%。

全球動脈切口閉合裝置市場正經歷強勁成長，主要促進因素是心血管疾病（CVD）盛行率的不斷上升，而心血管疾病是全球首要死因。血管成形術和冠狀動脈導管插入術等介入手術數量的增加，推動了對可靠動脈切口閉合解決方案的需求。醫院仍然是主要的終端用戶，因為高頻手術，尤其是涉及大口徑導管的手術，主要集中在專科中心。然而，由於門診血管手術具有成本效益高、週轉快等優點，市場對門診血管手術的需求日益成長，因此，門診手術中心（ASC）的使用量正在顯著增加。儘管中低收入國家面臨許多挑戰，但市場相關人員正致力於地域擴張和提高產品可負擔性，推動創新以改善這些地區的醫療服務。

全球動脈切開術閉合裝置市場促進因素

冠動脈攝影術、經皮冠狀動脈介入治療（PCI）、經導管主動脈瓣置換術術（TAVR）和周邊血管介入等介入性手術的日益增多，是推動動脈切開封堵器需求成長的主要因素。隨著醫療機構致力於改善患者預後，快速止血、縮短恢復時間和減少併發症（包括血腫和出血）的需求也日益凸顯。這種變化凸顯了血管閉合裝置在導管術後股動脈和橈動脈入路管理中的關鍵作用，鞏固了其作為現代醫學必備工具的地位，並促進了這些裝置的市場蓬勃發展。

限制全球動脈切開術閉合裝置市場的因素

先進動脈切開封堵器的廣泛應用，尤其是在發展中地區，面臨的一大障礙是這些系統的高成本。雖然手動壓迫仍然是一種經濟的選擇，但由於報銷不足、價格敏感以及缺乏必要的基礎設施，預算緊張的醫療機構不願採用新技術。因此，東南亞和拉丁美洲等新興市場的許多醫院由於先進設備成本高昂，主要依賴手動閉合方法，這阻礙了該領域的發展，儘管現代解決方案具有潛在的優勢。

全球動脈切開術閉合裝置市場趨勢

全球動脈切口閉合器械市場正經歷著向微創手術技術的重大轉變，這主要得益於市場對高效血管手術（可促進患者康復）需求的不斷成長。隨著醫療系統擴大採用經導管主動脈瓣置換術術 (TAVR) 和血管內動脈瘤修復術 (EVAR) 等大口徑介入治療，對能夠快速止血並改善手術效果的創新型血管閉合器材的需求也隨之激增。這一趨勢在已開發市場和新興市場均尤為明顯，器械技術的進步使得器械能夠快速部署並實現更精準的操作控制，從而最大限度地減少併發症，並支持複雜介入性心臟病學和血管外科手術的拓展。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 案例研究
• 顧客購買行為分析

全球動脈切開封堵器市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 主動閉合裝置
• 被動閉合裝置

全球動脈切開封堵器市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 股動脈路手術
• 橈動脈入路手術

全球動脈切開封堵器市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診治療中心
• 其他

全球動脈切開封堵器市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Abbott Laboratories
• Terumo Corporation
• Cardinal Health（Cordis）
• Boston Scientific Corporation
• Medtronic plc
• Teleflex Incorporated（Vascular Solutions）
• Vivasure Medical Ltd.
• TZ Medical, Inc.
• Meril Life Sciences Pvt. Ltd.
• Morris Innovative, Inc.

結論與建議

Global Arteriotomy Closure Devices Market size was valued at USD 1.94 Billion in 2024 and is poised to grow from USD 2.08 Billion in 2025 to USD 3.71 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global arteriotomy closure devices market is experiencing robust growth, largely driven by the increasing prevalence of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. As the volume of interventional procedures like angioplasty and coronary catheterization rises, the need for reliable arteriotomy closure solutions is intensifying. Hospitals remain the primary end-users due to the concentration of high-volume procedures in specialized centers, particularly those involving large bore catheter access. However, there is a notable shift towards ambulatory surgical centers (ASCs), reflecting a growing demand for outpatient vascular procedures driven by cost-efficiency and rapid recovery. Despite challenges in low- and middle-income countries, market players are focusing on geographic expansion and affordability, fostering innovation to enhance healthcare delivery in these regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Arteriotomy Closure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Arteriotomy Closure Devices Market Segments Analysis

Global Arteriotomy Closure Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Active Closure Devices and Passive Closure Devices. Based on Application, the market is segmented into Femoral Arterial Access Procedures and Radial Arterial Access Procedures. Based on End User, the market is segmented into Hospitals, Ambulatory Care Centers and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Arteriotomy Closure Devices Market

The increasing prevalence of interventional procedures, such as coronary angiography, percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and peripheral artery interventions, is significantly driving the demand for arteriotomy closure devices. As healthcare providers seek to enhance patient outcomes, there is a growing emphasis on the need for rapid hemostasis, minimized recovery times, and reduced complications, including hematoma and bleeding. This evolving landscape highlights the essential role of vascular closure devices in managing femoral and radial access during post-catheterization care, positioning them as indispensable tools in contemporary medical practice and contributing to a robust market for these devices.

Restraints in the Global Arteriotomy Closure Devices Market

A significant barrier to the wider adoption of advanced arteriotomy closure devices, particularly in developing regions, is the high cost associated with these systems. While manual compression remains an economical option, institutions in budget-limited markets hesitate to transition to newer technologies due to inadequate reimbursement frameworks, sensitivity to pricing policies, and a lack of necessary infrastructure. As a result, many hospitals in emerging markets, such as those in Southeast Asia and Latin America, primarily rely on manual closure methods due to the unaffordability of advanced devices, hindering progress in the field despite the potential benefits of modern solutions.

Market Trends of the Global Arteriotomy Closure Devices Market

The Global Arteriotomy Closure Devices market is witnessing a significant shift towards minimally invasive surgical techniques, driven by the rising preference for efficient vascular procedures that enhance patient recovery. As healthcare systems increasingly adopt large-bore interventions, such as Transcatheter Aortic Valve Replacement (TAVR) and Endovascular Aneurysm Repair (EVAR), the demand for innovative vascular closure devices capable of providing rapid hemostasis and improved surgical outcomes is intensifying. This trend is particularly prominent in both developed and emerging markets, where advancements in device technology enable faster deployment and superior operator control, thus minimizing complications and supporting the expansion of complex interventional cardiology and vascular surgery practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Arteriotomy Closure Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Active Closure Devices
• Passive Closure Devices

Global Arteriotomy Closure Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Femoral Arterial Access Procedures
• Radial Arterial Access Procedures

Global Arteriotomy Closure Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Care Centers
• Other

Global Arteriotomy Closure Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (Cordis)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (Vascular Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivasure Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TZ Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morris Innovative, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations